Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase II Open-Label Study of Sacituzumab Govitecan in Patients with Previously Treated Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma
Study Type: Treatment
Phase: II
NCTID: NCT06178588
Principal Investigator:
Anup Kasi
Randomized Open-Label Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced/Metastatic GI Cancers
Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction.
Study Type: Health Services
Phase: III
NCTID: NCT02270450
Principal Investigator:
Mazin Al-Kasspooles
A Phase 2 Basket Trial of Ulixertinib BVD-523 in Combination with Hydroxychloroquine in Patients with Advanced Gastrointestinal Malignancies Harboring MAPK Pathway Mutations BVD-523-HCQ
A phase I/II trial of Cabozantinib in combination with Durvalumab MEDI4736 with or without Tremelimumab in patients with advanced gastroesophageal cancer and other gastrointestinal GI malignancies CAMILLA
A Randomized And Placebo-Controlled Phase II Trial Targeting Dominant-Negative Missense Mutant P53 By Atorvastatin For Reducing The Risk Of Longstanding Ulcerative Colitis-Associated Cancer
A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors
Peak A Phase III Randomized, Open-label, Multicenter Clinical Study of CGT9486+Sunitinib vs Sunitinib in Subjects with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
Study Type: Treatment
Phase: III
NCTID: NCT05208047
Principal Investigator:
Benjamin Powers
An Open-Label Expanded Access Program Of Futibatinib TAS-120 In Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements
Study Type: Treatment
Phase: II
NCTID: NCT04507503
Principal Investigator:
Ravi Chuda